Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhengwei Song

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 1, 2024
Unveiling the promise of PD1/PD-L1: A new dawn in immunotherapy for cholangiocarcinomaFei Chen, Jian Sheng, Xiaoping Li, et al.
Nanomaterials (Basel, Switzerland)|August 30, 2020
Facile Synthesis of Ultrastable Fluorescent Copper Nanoclusters and Their Cellular Imaging ApplicationWei Yan, Jianqiao Zhang, Muhammad Abbas, et al.
American Journal of Translational Research|January 22, 2019
AMPK-related kinase 5 (ARK5) enhances gemcitabine resistance in pancreatic carcinoma by inducing epithelial-mesenchymal transitionXiaoguang Wang, Zhengwei Song, Fei Chen, et al.
Journal of Nanobiotechnology|April 4, 2025
Inflammation-targeted nanomedicine prevents tumor metastasis following photodynamic therapy by reversing epithelial-mesenchymal transition and ROS-mediated immunosuppressionZhengwei Song, Quanwei Sun, Wenshuo Yang, et al.
Cell Death & Disease|February 6, 2025
Overcoming immunotherapy resistance in gastric cancer: insights into mechanisms and emerging strategiesDingtian Luo, Jing Zhou, Shuiliang Ruan, et al.
Molecular Cancer|July 16, 2024
PD1/PD-L1 blockade in clear cell renal cell carcinoma: mechanistic insights, clinical efficacy, and future perspectivesZhaoyang Zhu, Yigang Jin, Jing Zhou, et al.
Oncology Reports|July 28, 2016
Synergistic inhibition of characteristics of liver cancer stem-like cells with a combination of sorafenib and 8-bromo-7-methoxychrysin in SMMC-7721 cell lineHui Zou, Xiaozheng Cao, Qiao Xiao, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 9, 2026
Toward Nano-Nutritional Medicine: A Remotely Activated Trans-Vaccenic Acid-Based Lipid Nanoparticles for Enhancing Immune Checkpoint Blockade TherapyKang Liu, Yunlong Li, Hanmeng Liu, et al.
Nanomaterials (Basel, Switzerland)|August 8, 2020
Highly Luminescent Copper Nanoclusters Stabilized by Ascorbic Acid for the Quantitative Detection of 4-AminoazobenzeneQiang Li, Yunhao Li, Heguo Li, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 19, 2025
Transforming tumors into 'high-risk bombs' triggers a neoantigen storm and amplifies immune responsesYunlong Li, Quanwei Sun, Zexin Yang, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 1, 2024
Unveiling the promise of PD1/PD-L1: A new dawn in immunotherapy for cholangiocarcinomaFei Chen, Jian Sheng, Xiaoping Li, et al.
Nanomaterials (Basel, Switzerland)|August 30, 2020
Facile Synthesis of Ultrastable Fluorescent Copper Nanoclusters and Their Cellular Imaging ApplicationWei Yan, Jianqiao Zhang, Muhammad Abbas, et al.
American Journal of Translational Research|January 22, 2019
AMPK-related kinase 5 (ARK5) enhances gemcitabine resistance in pancreatic carcinoma by inducing epithelial-mesenchymal transitionXiaoguang Wang, Zhengwei Song, Fei Chen, et al.
Journal of Nanobiotechnology|April 4, 2025
Inflammation-targeted nanomedicine prevents tumor metastasis following photodynamic therapy by reversing epithelial-mesenchymal transition and ROS-mediated immunosuppressionZhengwei Song, Quanwei Sun, Wenshuo Yang, et al.
Cell Death & Disease|February 6, 2025
Overcoming immunotherapy resistance in gastric cancer: insights into mechanisms and emerging strategiesDingtian Luo, Jing Zhou, Shuiliang Ruan, et al.
Molecular Cancer|July 16, 2024
PD1/PD-L1 blockade in clear cell renal cell carcinoma: mechanistic insights, clinical efficacy, and future perspectivesZhaoyang Zhu, Yigang Jin, Jing Zhou, et al.
Oncology Reports|July 28, 2016
Synergistic inhibition of characteristics of liver cancer stem-like cells with a combination of sorafenib and 8-bromo-7-methoxychrysin in SMMC-7721 cell lineHui Zou, Xiaozheng Cao, Qiao Xiao, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 9, 2026
Toward Nano-Nutritional Medicine: A Remotely Activated Trans-Vaccenic Acid-Based Lipid Nanoparticles for Enhancing Immune Checkpoint Blockade TherapyKang Liu, Yunlong Li, Hanmeng Liu, et al.
Nanomaterials (Basel, Switzerland)|August 8, 2020
Highly Luminescent Copper Nanoclusters Stabilized by Ascorbic Acid for the Quantitative Detection of 4-AminoazobenzeneQiang Li, Yunhao Li, Heguo Li, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 19, 2025
Transforming tumors into 'high-risk bombs' triggers a neoantigen storm and amplifies immune responsesYunlong Li, Quanwei Sun, Zexin Yang, et al.
Pageof 5